InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the detailed record of transactions filed by Coulie Bernard, Chief Executive Officer. Officer active across 1 companies, notably Pliant Therapeutics, INC.. Aggregated, 6 filings have been logged. Total volume traded: €543k. The latest transaction was filed on 20 January 2026 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
US$98,28989,375 shares@ US$1.09970.13% mcap36.2% of flow
Common Stock
SEC:0001746473-26-000009·
€98,28989,375 shares@ €1.09970.13% mcap18.1% of flow
Common Stock
SEC:0001746473-26-000009:0·
€102,2223,757 shares@ €27.20840.14% mcap37.7% of flow
Common Stock
SEC:0001209191-21-040760·
€102,2223,757 shares@ €27.20840.14% mcap18.8% of flow
Common Stock
SEC:0001209191-21-040760:0·
€70,7932,997 shares@ €23.62130.094% mcap26.1% of flow
Common Stock
SEC:0001209191-21-033310·
€70,7932,997 shares@ €23.62130.094% mcap13.0% of flow
Common Stock
SEC:0001209191-21-033310:0·
6 of 6 declarations
About Coulie Bernard
Bernard Coulie is the President and CEO of PLIANT THERAPEUTICS, INC. He is responsible for the strategic and operational leadership of the company. Coulie plays a key role in developing new products and expanding the company's activities.
